A phase-appropriate plasmid DNA CMC and GMP manufacturing platform supporting IVT templates, plasmid raw materials, and DNA drug product programs from early research to clinical and commercial-stage needs.
Vector construction, strain banking, fermentation, purification, analytics, and release testing.
Flexible plasmid GMP manufacturing from early-stage programs to DNA drug product needs.
Platform Scope
Plasmid raw material, IVT template, and DNA drug product manufacturing support.
Process Routes
Manufacturing routes for supercoiled plasmid and linearized IVT template.
Process Design
Classical three-step, two-step, and one-step process options based on application, timeline, and cost needs.
Template Control
Backbone stability, poly(A) integrity, and linearization strategy for IVT template performance.
GMP Scale Proof
Flexible plasmid GMP manufacturing scale from development to larger-scale production.
Quality Proof
Supercoiled plasmid ratio target supported by purification and analytical control.

Take a closer look at CATUG’s plasmid GMP suites, flexible production lines, facility design, quality systems, and tech transfer readiness.
CATUG combines small-scale PCV/IIT lines, single-use systems, and stainless-steel production lines to support fit-for-purpose GMP manufacturing based on project stage, product characteristics, timeline, contamination-control needs, and cost considerations.
Our GMP facilities are designed with unidirectional flow and full-air-exhaust principles, supported by quality systems covering QA oversight, batch records, deviation management, change control, release testing, data integrity, and full traceability.
Multiple GMP lines enable parallel project execution, flexible scheduling, and efficient scale selection from early development and engineering runs to clinical supply and larger-scale GMP manufacturing.
CATUG has successfully passed EU QP audit and maintained a 100% audit pass rate, while supporting structured technology transfer covering process handover, risk assessment, manufacturing readiness, and execution into GMP production.